Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Urges Stockholders To Turn Down Roche's Offer & Vote For Its Nominees

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) said it is sending a letter from its Board of Directors highlighting supportive reports issued by two of the nation's leading proxy advisor firms. The company's Board recommends that stockholders reject Roche's (RHHBY.PK) offer and vote for the election of its highly qualified nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card on April 9, 2012.

Illumina also urged its shareholders to vote the WHITE PROXY CARD to re-elect to the Board four highly qualified and experienced directors, Blaine Bowman; Karin Eastham; Jay Flatley, President and CEO; and William Rastetter, Chairman.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer Gap Inc. said Thursday after the markets closed that its second quarter profit rose 10% from last year, helped by higher sales and a gain from asset sale. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarter sales. Separately, Gap announced plans to enter India through franchise-operated Gap brand stores in 2015. While buying interest was somewhat subdued, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day extended the recent upward trend by the markets, lifting the S&P 500 to a new record closing high. Republicans have not found much to like about President Barack Obama's nearly six years in office, but the results of a new Washington Post-ABC News poll show that a vast majority support the president's decision to launch airstrikes in Iraq.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.